Somerset Hunterdon Warren Psychological Association (SHWPA)
Jill M. Williams, MD
“Addressing the Opioid Epidemic: A Primer on Opioid Addiction, Overdose Management, and Medications for Opioid Use Disorder"
ZOOM ONLY – Register at shwpa.org
Friday, March 13, 2026, Welcome and Intro 12:45; Program 1-2pm
1 OPIOID Continuing Education Credit
Program Overview: The Rutgers Interdisciplinary Opioid Trainers (RIOT) Presentation, titled Addressing the Opioid Epidemic: A Primer on Opioid Addiction, Overdose Management, and Medications for Opioid Use Disorder, provides a broad overview of the current US opioid crisis. The presentation includes information on opioid use disorder (OUD), overdose management, and Medications for Opioid Use Disorder (MOUD). Delivered by graduate students from Rutgers University, including those in medicine, pharmacy, and public health, the presentation explores how social, economic, and cultural factors contribute to substance use patterns and influence access to care. It highlights systemic barriers to treatment and examines MOUD options, including Methadone, Buprenorphine and Naltrexone. The presentation also discusses the bio- psycho-social-spiritual framework and emphasizes the importance of comprehensive, inclusive, and patient-centered approaches to treatment and recovery. Our goal is to reduce stigma and increase awareness about the opioid crisis and MOUDs.
Jill M. Williams, MD, is a Professor of Psychiatry and Director of the Division of Addiction Psychiatry at Rutgers University, Robert Wood Johnson Medical School in New Brunswick, NJ. She received her medical degree at Robert Wood Johnson Medical School and completed psychiatry residency training at Duke University. The focus of Dr. Williams work has been in addressing tobacco in individuals with mental illness or other addictions through treatment and systems interventions. Her work has been published in journals including JAMA, Nicotine and Tobacco Research and featured in US News and World Report. She is Medical Director for the TCTTAC Program in NYC, in collaboration with Center for Practice Innovation at Columbia University. In 2015 she was the recipient of the Remarkable Achievement Award of the NJ Psychiatric Association. She is a Distinguished Life Fellow of the American Psychiatric Association and former Chairperson for the APA Council on Addiction Psychiatry. She is co-author of the 2025 book entitled 'Treating Addiction to Tobacco and Nicotine Products, a Guidebook for Clinicians', published by APA Press.
Learning Objectives:
1. Participants will learn about and understand the factors that led to the US opioid crisis.
2. Participants will learn the proper uses of naloxone for overdose reversal.
3. Participants will learn to recognize the signs of opioid use disorder.
4. The presenter will provide information to debunk commonly held myths and beliefs about treatment for opioid use disorder.
5. Participants will learn about and understand the key role of MOUD (Medication for Opioid Use Disorder) in enhancing outcomes.
Dr. Williams does not have any commercial support or any conflict of interest with this program.
The programs level of learning is intermediate, and the target audience is psychologists.
ADA Accommodations available upon written request by emailing Virginia Walters, Psy.D. at virginiawaltersm4@gmail.com no later than March 6, 2026.
SHWPA Program Fee: SHWPA Member $35.00 Non-SHWPA Member $50.00 Students $15.
Register at shwpa.org or mail a check to SHWPA - P.O. Box 242, Oldwick, NJ 08858.
Please make check payable to SHWPA and indicate it is for the 3/13/26 program. Registration for this program will be closed on March 6, 2026.
NJPA CE Credit / Administrative Fee for 1 Opioid CE credit is paid to NJPA online before the program. The NJPA Link will be emailed prior to this program.
NJPA administrative fees: NJPA Member $15; Non-NJPA Member $40. NJPA will email the Program Evaluation to you after the program. Non-NJPA Members can create a non-member account on the NJPA website at no cost.
This workshop is co-sponsored by NJPA and SHWPA. NJPA is approved by the American Psychological Association (APA) to offer continuing education for psychologists. NJPA maintains responsibility for the program and its content.